Organogenesis Hldgs Stock (NASDAQ: ORGO) stock price, news, charts, stock research, profile.
Open | $2.290 |
Close | - |
Volume / Avg. | 493.716K / 822.606K |
Day Range | 2.260 - 2.390 |
52 Wk Range | 1.795 - 4.705 |
Market Cap | $308.134M |
P/E Ratio | 57.125 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 32 |
Short Interest | 23.73% |
Days to Cover | 13.81 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Organogenesis Hldgs (NASDAQ: ORGO) through any online brokerage.
Other companies in Organogenesis Hldgs’s space includes: Inozyme Pharma (NASDAQ:INZY), Adaptimmune Therapeutics (NASDAQ:ADAP), Opthea (NASDAQ:OPT), Monte Rosa Therapeutics (NASDAQ:GLUE) and RAPT Therapeutics (NASDAQ:RAPT).
The latest price target for Organogenesis Hldgs (NASDAQ: ORGO) was reported by Cantor Fitzgerald on Friday, March 1, 2024. The analyst firm set a price target for 5.00 expecting ORGO to rise to within 12 months (a possible 114.13% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Organogenesis Hldgs (NASDAQ: ORGO) is $2.335 last updated Today at April 26, 2024 at 12:12 PM EDT.
There are no upcoming dividends for Organogenesis Hldgs.
Organogenesis Hldgs’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Organogenesis Hldgs.
Organogenesis Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.